Drug safety expert Dr JosÃ© Vega from Amgen presented at the World Drug Safety Congress Americas in 2011 and you can now download his presentation here!
Dr JosÃ© Vega is Vice President Global Safety, Amgen and in this presentation entitled “Drug safety: emerging trends and future directions for the biopharmaceutical industry” he looks at
â¢ The growing importance of observational research in drug safety
â¢ Active surveillance programs in the post-marketing setting
â¢ Early planning for risk minimization activities during the drug development life cycle
â¢ Importance of core involvement of the safety group on product teams
To hear more from drug safety industry and pharmacovigilance leaders including representatives from Abbott, AstraZeneca, Genzyme, Roche, Boehringer Ingelheim, Forest Laboratories, Health Canada and Pfizer register now for the World Drug Safety Congress Americas 2012